FDA Drug recall D-1064-2014
Namenda XR (memantine HCl), titration pack (7 mg, 14 mg, 21 mg and 28 mg) extended release capsules, packaged in 28-capsule, 4 week, titrat…
- FDA Drug
- Class III
- terminated
- Published 2014-02-12
On 2014-02-12 the FDA classified a Class III recall of Namenda XR (memantine HCl), titration pack (7 mg, 14 mg, 21 mg and 28 mg) extended release capsules, packaged in 28-capsule, 4 week, titrat… by Forest Pharmaceuticals, citing failed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1064-2014 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2013-11-13 |
| Published | 2014-02-12 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Forest Pharmaceuticals |
| Distribution | US |
Product
Namenda XR (memantine HCl), titration pack (7 mg, 14 mg, 21 mg and 28 mg) extended release capsules, packaged in 28-capsule, 4 week, titration pack,Rx only, Forest Pharmaceuticals Inc., St. Louis, MO 63045 NDC 0456-3400-29.
Reason
Failed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.
Identifiers
| code_info | Lot 1113661 Exp. 01/15 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1064-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.